RAPT Therapeutics Dirección
Dirección controles de criterios 2/4
RAPT Therapeutics' El consejero delegado es Brian Wong , nombrado en Aug 2015, tiene un mandato de 8.33 años. la remuneración anual total es $5.21M , compuesta por 11.1% salario y 88.9% primas, incluidas acciones y opciones de la empresa. posee directamente 1.41% de las acciones de la empresa, por valor de $8.46M . La antigüedad media del equipo directivo y del consejo de administración es de 4 años y 6.6 años respectivamente.
Información clave
Brian Wong
Chief Executive Officer (CEO)
US$6.6m
Compensación total
| Porcentaje del salario del CEO | 9.2% |
| Permanencia del CEO | 8.7yrs |
| Participación del CEO | 1.4% |
| Permanencia media de la dirección | 4.2yrs |
| Promedio de permanencia en la Junta Directiva | 6.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Is RAPT Therapeutics (NASDAQ:RAPT) In A Good Position To Invest In Growth?
Feb 21
We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
Sep 12We Think RAPT Therapeutics (NASDAQ:RAPT) Can Afford To Drive Business Growth
May 10We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Feb 07We're Hopeful That RAPT Therapeutics (NASDAQ:RAPT) Will Use Its Cash Wisely
Oct 12RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jan 25RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Oct 15RAPT Therapeutics (RAPT) skyrockets 100% on positive RPT193 data in early-stage atopic dermatitis study
Jun 14RAPT Therapeutics (NASDAQ:RAPT) Is In A Good Position To Deliver On Growth Plans
Jun 08Should You Take Comfort From Insider Transactions At RAPT Therapeutics, Inc. (NASDAQ:RAPT)?
Mar 15We Think RAPT Therapeutics (NASDAQ:RAPT) Can Easily Afford To Drive Business Growth
Feb 15
RAPT Therapeutics' (NASDAQ:RAPT) Stock Price Has Reduced 56% In The Past Year
Jan 18RAPT Therapeutics: Interesting Asset, But Doubtful History And Bad Market Reaction
Jan 08Here's What RAPT Therapeutics, Inc.'s (NASDAQ:RAPT) Shareholder Ownership Structure Looks Like
Dec 21The Independent Chairman of the Board of RAPT Therapeutics, Inc. (NASDAQ:RAPT), William Rieflin, Just Bought 12% More Shares
Nov 23Earnings Beat: RAPT Therapeutics, Inc. (NASDAQ:RAPT) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Nov 19RAPT Therapeutics tumbles 25% despite promising FLX475 data in multiple cancers
Nov 16Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$7m | US$605k | -US$117m |
| Sep 30 2023 | n/a | n/a | -US$109m |
| Jun 30 2023 | n/a | n/a | -US$99m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$5m | US$580k | -US$84m |
| Sep 30 2022 | n/a | n/a | -US$79m |
| Jun 30 2022 | n/a | n/a | -US$76m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$540k | -US$69m |
| Sep 30 2021 | n/a | n/a | -US$64m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$56m |
| Dec 31 2020 | US$4m | US$500k | -US$53m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$49m |
| Mar 31 2020 | n/a | n/a | -US$47m |
| Dec 31 2019 | US$2m | US$447k | -US$43m |
| Sep 30 2019 | n/a | n/a | -US$39m |
| Jun 30 2019 | n/a | n/a | -US$40m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$1m | US$425k | -US$36m |
Compensación vs. Mercado: Brian($USD5.21M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD2.23M).
Compensación vs. Ingresos: La compensación de Brian ha aumentado mientras la empresa no es rentable.
CEO
Brian Wong (51 yo)
8.7yrs
Permanencia
US$6,591,617
Compensación
Dr. Brian Russell Wong, M.D., Ph.D. serves as Venture Partner at The Column Group, LLC since joining the firm in 2022. He has been Chief Executive Officer and Director at RAPT Therapeutics, Inc. since Augu...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 8.7yrs | US$6.59m | 1.42% $ 4.5m | |
| CFO, Principal Accounting Officer & Secretary | 4.3yrs | US$2.18m | 0.034% $ 107.8k | |
| Chief Medical Officer | 8.9yrs | US$1.90m | 0.045% $ 144.6k | |
| Vice President of Technology | no data | sin datos | sin datos | |
| Chief Scientific Officer | 4.8yrs | US$1.48m | 0.074% $ 237.3k | |
| General Counsel | 1.3yrs | sin datos | sin datos | |
| Chief Human Resources Officer | 1.9yrs | sin datos | sin datos | |
| Senior Vice President of Quantitative & Computational Biology | 4.1yrs | sin datos | sin datos | |
| Senior Vice President of Drug Discovery & Preclinical Development | 5.3yrs | sin datos | sin datos | |
| Senior Vice President of Regulatory Affairs & Quality Assurance | 1.6yrs | sin datos | sin datos | |
| Senior Vice President of Technical Operations | less than a year | sin datos | sin datos |
4.2yrs
Permanencia media
56.5yo
Promedio de edad
Equipo directivo experimentado: RAPTEl equipo directivo de la empresa se considera experimentado (4 años de antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 8.7yrs | US$6.59m | 1.42% $ 4.5m | |
| Independent Chairman of the Board | 8.9yrs | US$175.46k | 0.27% $ 870.5k | |
| Independent Director | 4.3yrs | US$152.96k | 0% $ 0 | |
| Member of Scientific Advisory Board | 6.9yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 6.9yrs | sin datos | sin datos | |
| Chairman of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 6.6yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 4.8yrs | sin datos | sin datos | |
| Independent Director | 6.3yrs | US$267.78k | 0% $ 0 | |
| Independent Director | 7.3yrs | US$260.78k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
6.9yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de RAPT se considera experimentada (6.6 años de antigüedad promedio).